New at-home light therapy could help fight gum disease
NCT ID NCT05698823
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a home-use device that uses dual-light therapy and a special mouth rinse to help control chronic gum disease. Fifty-six adults with advanced periodontitis used the device regularly. The goal was to see if it reduces gum bleeding and improves plaque control, which could help manage the disease long-term.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lumoral treatment device with Lumorinse mouth rinse
- What this could lead to
- If it works, this could offer a convenient at-home method to help manage chronic gum disease and reduce the need for frequent dental visits.
- What could go wrong
- This is a small, completed study with 56 participants. The device is meant to support standard care, not replace it, and results may not apply to everyone with gum disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
56 people
The number who actually took part.
- Started
-
Jun 2023
- Finished
-
Jan 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Periodontal disease stage III-IV, according to criteria the American Academy of Periodontology (AAP) with at least 3 mm interdental clinical attachment level (CAL) in the site of greatest loss. * ≥ 18 years old * Presence of ≥20 teeth, including implants * Agreement to participate in the study and to sign a written consent form * Able to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocol Exclusion Criteria: * Grade A or C periodontitis * Presence of any physical limitation or restriction that might restrict Lumoral use * Pregnancy or lactation * Active smoking * Medicated diabetes mellitus (DM) * Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of periodontal disease * Use of antibiotics within 4 weeks week prior study * Periodontal treatment within 3 months prior study * Removable major prosthesis or major orthodontic appliance * A need for a hopeless teeth extraction, or open cavities in need for immediate endodontic treatment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontitis chronic generalized moderate are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Department of Dental and Oral Pathology
Kaunas, 50161, Lithuania
More trials for these conditions
Other studies related to the condition(s) this trial covers.